Taysha Gene Therapies Number of Employees 2020-2024 | TSHA
Taysha Gene Therapies number of employees from 2020 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Taysha Gene Therapies Annual Employee Count |
| 2024 |
73 |
| 2023 |
52 |
| 2022 |
65 |
| 2021 |
178 |
| 2020 |
38 |
| 2019 |
10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.254B |
$0.008B |
|
Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.
|
